Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.76−0.01 (-0.27%)
Close on Nov 17, 2026Market cap $91.09MP/E –Yield –
Exagen EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Exagen
Exagen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?